Metastasis is the process by which cancer cells spread from where they first formed to other parts of the body. It is the primary reason cancer becomes life-threatening. A nationwide registry study found that at least two-thirds of all deaths from solid tumors are caused by metastatic spread rather than by the original tumor itself. When cancer has metastasized, it is classified as Stage IV, the most advanced stage.
How Cancer Cells Spread
Cancer doesn’t jump from one organ to another in a single leap. It follows a sequence of steps, sometimes called the metastatic cascade, and a cancer cell must survive every step to successfully form a new tumor elsewhere. The process begins when cells at the edge of the original tumor push into surrounding healthy tissue. To do this, cancer cells undergo a transformation that makes them more mobile and invasive, essentially switching from a stationary cell type to one capable of crawling through tissue.
Once they’ve invaded nearby tissue, cancer cells enter the bloodstream or lymphatic system. This is the most dangerous transition, because it gives them access to the entire body. Surviving in the bloodstream is difficult for a cancer cell. It faces physical shearing forces, attacks from the immune system, and a lack of the supportive signals it had in the original tumor. The vast majority of circulating tumor cells die in transit.
The cells that do survive must then exit the bloodstream by squeezing through vessel walls into a new organ. Even after arriving, most still fail. The final and rarest step is colonization: a cancer cell must adapt to its new environment, begin dividing, and eventually grow into a visible tumor. This entire cascade is remarkably inefficient, which is why metastasis typically takes months or years to develop despite millions of cells potentially entering the bloodstream from a growing tumor.
Where Different Cancers Tend to Spread
Metastasis doesn’t happen randomly. Certain cancers strongly favor specific organs. The four most common destinations are bone, lung, liver, and brain. This pattern isn’t just about blood flow and anatomy. The tissue environment at each site plays a role in whether arriving cancer cells can survive and grow, a concept sometimes described as “seed and soil” compatibility.
Breast and prostate cancers are the most likely to spread to bone, with roughly 65 to 75% of metastatic breast cancer patients and over 80% of advanced prostate cancer patients developing bone involvement. Lung and kidney cancers spread to bone in about 40% of cases. Cancers of the breast, colon, bladder, kidney, and melanoma all have a tendency to spread to the lungs. The liver is a frequent target for colorectal cancer, melanoma, lung cancer, and breast cancer, with about 40 to 50% of women with metastatic breast cancer developing liver involvement during the course of their disease. Brain metastases occur in more than 40% of all cancer patients overall, and nearly half of lung cancer patients specifically.
Symptoms Depend on Where It Spreads
Metastatic cancer sometimes causes no symptoms at all, especially early on. When symptoms do appear, they reflect which organ is affected rather than the type of cancer that originally started the process. A breast cancer that has spread to bone is still breast cancer, but the symptoms it causes are bone symptoms.
Bone metastasis commonly causes persistent pain in the affected area, bones that fracture more easily than normal, and elevated calcium levels in the blood. High calcium can lead to nausea, vomiting, constipation, and confusion. When bone metastasis occurs in the spine, it can create pain and stiffness in the neck or back from pressure on the spinal cord. Liver metastasis often causes fatigue, abdominal swelling, and jaundice (yellowing of the skin and eyes). Brain metastasis can produce headaches, seizures, vision changes, or difficulty with balance and coordination. Lung metastasis may cause a persistent cough, shortness of breath, or chest pain.
How Metastasis Is Detected
The standard staging system used worldwide assigns an “M” category to every cancer diagnosis. M0 means there is no detectable spread to distant organs. M1 means cancer has been found in another part of the body. Any cancer classified as M1 is considered Stage IV regardless of the size of the original tumor.
Imaging scans like CT, MRI, PET, and bone scans are the most common tools for finding metastases. But a newer approach called liquid biopsy is gaining ground. This minimally invasive blood test can detect circulating tumor cells and fragments of tumor DNA floating in the bloodstream. The technique uses methods like immunomagnetic separation, where magnetic particles coated with antibodies latch onto cancer cells and pull them out of a blood sample, and microfluidic devices that filter cancer cells based on their larger size compared to normal blood cells. Liquid biopsies are particularly useful for catching very early signs of spread and for monitoring whether a treatment is working, since the number of circulating tumor cells can change over time.
Why Cancer Can Return Years Later
One of the most unsettling aspects of metastasis is that it can appear years or even decades after successful treatment of the original tumor. This happens because some cancer cells that reached distant organs entered a state of dormancy. These dormant cells are not dividing, but they’re also not dying. They sit quietly in tissues like bone marrow, essentially invisible to standard treatments like chemotherapy, which targets actively dividing cells.
What wakes them up isn’t fully understood, but several triggers have been identified. Inflammation appears to play a significant role, activating molecular pathways that push dormant cells back into a growth phase. The organ environment matters too. The lung, for example, with its high oxygen levels and specific chemical signals, tends to reactivate dormant cells more readily than some other tissues. Certain signaling molecules released by the body’s own bone marrow cells can also be recruited to future metastatic sites, effectively preparing the ground for dormant cells to reawaken and begin forming new tumors.
Treatment for Metastatic Cancer
Once cancer has spread, treatment generally shifts from trying to eliminate the disease entirely to controlling its growth and managing symptoms. The two broad categories are local treatments, which target specific tumor sites, and systemic treatments, which travel through the entire body. Systemic options include chemotherapy, immunotherapy, and targeted therapy. Local options include surgery and high-dose radiation directed at individual metastatic tumors.
The sequencing of these treatments matters. Starting with systemic therapy can shrink tumors throughout the body and reveal which ones respond to treatment, helping doctors identify patients who would genuinely benefit from follow-up surgery or focused radiation. Alternatively, removing a metastatic tumor first can reduce the overall burden on the body before systemic treatment begins. Evidence from studies of patients with limited metastatic spread suggests that systemic therapy followed by local treatment to remaining sites may offer the best outcomes for survival.
For some patients with only a small number of metastatic tumors, sometimes called oligometastatic disease, aggressive local treatment of each site combined with systemic therapy can lead to long-term control. For others with widespread metastasis, the goal is to slow progression and maintain quality of life for as long as possible. The specific approach depends on the cancer type, where it has spread, how many sites are involved, and how the cancer responds to initial treatment.